Passive enhanced safety surveillance for Vaxigrip and Intanza 15 µg in the United Kingdom and Finland during the northern hemisphere influenza season 2015/16

Enhanced safety surveillance (ESS) was conducted in the United Kingdom and Finland for Vaxigrip and Intanza 15 µg to comply with the European Medicines Agency interim guidance aimed to detect any potential increase in reactogenicity in near real time following the annual update of the influenza vacc...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Euro Surveill
Hlavní autoři: Bricout, Hélène, Chabanon, Anne Laure, Souverain, Audrey, Sadorge, Christine, Vesikari, Timo, Caroe, Timothy David
Médium: Artigo
Jazyk:Inglês
Vydáno: European Centre for Disease Prevention and Control (ECDC) 2017
Témata:
Surveillance and Outbreak Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5434878/
https://ncbi.nlm.nih.gov/pubmed/28494843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2807/1560-7917.ES.2017.22.18.30527
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky